View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Durvalumab 1500 / Gemcitabine 1250 / Cisplatin 75, Non-Small Cell Lung Cancer, neoadjuvant, Cycle 1-4
Protocol-ID: 2493 V1.0 (Mini), DURV1500/GEMC1250/CISP75, NSCLC, neoadj., C1-4Indication(s)
- Lung Carcinoma, Non-Small Cell (Squamous Cell Carcinoma); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 15.11.2023